(Q40224621)

18 September 2017

Tumor suppressor activity of glucocorticoid receptor in the prostate (English)

1 reference

18 September 2017

Yemelyanov A

1

1 reference

18 September 2017

Czwornog J

2

1 reference

18 September 2017

Chebotaev D

3

1 reference

18 September 2017

Karseladze A

4

1 reference

18 September 2017

Kulevitch E

5

1 reference

18 September 2017

Yang X

6

1 reference

18 September 2017

Budunova I

7

1 reference

18 September 2017

language of work or name

English

0 references

publication date

2 October 2006

1 reference

18 September 2017

1 reference

18 September 2017

26

1 reference

18 September 2017

13

1 reference

18 September 2017

1885-1896

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209991

18 September 2017

0 references

cites work

Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Delineation of prognostic biomarkers in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Glucocorticoids and treatment of prostate cancer: a preclinical and clinical review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Glucocorticoids Inhibit Lung Cancer Cell Growth through Both the Extracellular Signal-Related Kinase Pathway and Cell Cycle Regulators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Androgen receptor signaling in androgen-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Protein-DNA array-based identification of transcription factor activities regulated by interaction with the glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Diagnostic utility of alpha-methylacyl CoA racemase (P504S) on prostate needle biopsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Hepsin promotes prostate cancer progression and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Combination of dexamethasone and a somatostatin analogue in the treatment of advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Mitogen Activated Protein kinase signal transduction pathways in the prostate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

New advances on prostate carcinogenesis and therapies: involvement of EGF-EGFR transduction system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Rapid signalling by androgen receptor in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Molecular markers of prostate cancer outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Molecular mechanisms of glucocorticoid resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

The p38 transduction pathway in prostatic neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Mechanisms involved in the side effects of glucocorticoids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Role of Maspin in Tumor Metastasis and Angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Differential expression of steroid receptors in prostate tissues before and after radiation therapy for prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209991

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209991

1 reference

Dimensions Publication ID

18 September 2017

0 references

1 reference